Welcome, Guest. Please login or register.
July 21, 2024, 10:31:50 pm

Login with username, password and session length

  • Total Posts: 55130
  • Total Topics: 4851
  • Online Today: 219
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 61
Total: 61


Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Screening for Hepatitis B Before Chemotherapy Is Cost Effective  (Read 8288 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
Compared with not screening at all or screening only those at the highest risk for the virus, universal screening for hepatitis B virus (HBV) before individuals receive chemotherapy for solid tumors is the most cost-effective option, Healio reports.

Chemotherapy for solid tumors can suppress the immune system and raise the risk of reactivation of HBV.

Gauree G. Konijeti, MD, of the Scripps Clinic in San Diego, and colleagues conducted modeling of a theoretical population of U.S. adults who started chemotherapy for a solid tumor. Publishing their findings in Clinical Gastroenterology and Hepatology, they compared three screening strategies, including a screen-all strategy, screening only the high-risk patients or screening none.

For more...


© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.